This test is most useful if any of these apply to you.
If you want to know whether your body is getting enough protein, fighting hidden inflammation, or quietly losing nutritional ground, prealbumin is the fastest routine blood marker that answers those questions. While albumin, its better-known cousin, takes weeks to shift, prealbumin turns over in roughly two to three days. That means it catches problems sooner and responds to changes faster.
A large study of over 35,000 adults from the UK Biobank found that lower prealbumin levels were associated with a higher risk of heart failure and death from any cause. That finding moves prealbumin beyond the hospital bedside and into the conversation about long-term health monitoring, especially if you want an early signal that something is off before you feel sick.
Prealbumin is actually a protein called transthyretin (TTR). Despite the name, it is not a precursor to albumin. The "pre" refers to the fact that it migrates ahead of albumin on a laboratory separation technique called electrophoresis. Its real job is to carry thyroid hormone (thyroxine, or T4) and vitamin A through your bloodstream.
Your liver makes prealbumin, and your kidneys break it down. Because it has a half-life of only about two to three days, your blood level responds quickly to changes in protein intake, calorie status, and inflammation. Albumin, by comparison, has a half-life of roughly 20 days, so it lags far behind.
Prealbumin is also what scientists call a negative acute-phase reactant. That means when your body is fighting infection, recovering from surgery, or dealing with chronic inflammation, the liver shifts its production away from prealbumin and toward inflammatory proteins. Your prealbumin drops even if you are eating well. Understanding this dual sensitivity, to both nutrition and inflammation, is the key to reading your result correctly.
In a study of 514 people hospitalized for acute heart failure, those discharged with prealbumin at or below 15 mg/dL were roughly twice as likely to die from heart-related causes within six months compared to those with higher levels. They were also about 50% more likely to be readmitted. These associations held even after adjusting for age, kidney function, inflammatory markers, and medications.
The UK Biobank analysis reinforced this pattern in a much broader population. Among over 35,000 participants, lower prealbumin levels were independently linked to greater risk of heart failure and all-cause death. The connection was especially strong in carriers of the V142I variant of the transthyretin gene, a mutation found predominantly in people of African descent.
If your prealbumin is low and you have any family history of heart failure, thickened heart muscle, or unexplained shortness of breath, it is worth discussing transthyretin amyloid cardiomyopathy (ATTR-CM) with a cardiologist. In ATTR-CM, the prealbumin protein itself misfolds and deposits in the heart. A study of 278 older Black adults with heart failure found that 39% of those carrying the V142I variant had developed this condition.
In people with gastric cancer, lower prealbumin before surgery predicts worse long-term survival. A study of 4,732 patients who underwent stomach cancer surgery found that those with lower preoperative prealbumin had shorter survival, largely because low prealbumin signaled a body already weakened by inflammation and poor nutrition.
Combining prealbumin with CRP (a standard inflammation marker) into a ratio appears to sharpen the signal. In a post hoc analysis of 419 gastric cancer patients from a randomized trial, a high CRP-to-prealbumin ratio before surgery predicted recurrence more accurately than other commonly used inflammatory scores.
These findings do not mean prealbumin causes cancer or predicts who will develop it. Instead, they show that when the body is under significant stress, prealbumin is one of the first proteins to reflect that burden. For anyone recovering from surgery or managing a serious illness, tracking prealbumin can reveal whether your body is rebuilding or still losing ground.
In people on hemodialysis (a treatment that filters blood through a machine when the kidneys can no longer do so), low prealbumin is one of the strongest predictors of death. A five-year follow-up of 798 hemodialysis patients found that those whose prealbumin dropped by 10 mg/dL or more over six months had about 37% higher mortality risk, even after adjusting for inflammatory markers and other nutritional measures.
In peritoneal dialysis (a different type of kidney replacement therapy), prealbumin behaves somewhat differently. Because the kidneys normally break down prealbumin, people with very little kidney function often have elevated levels. In a study of 220 peritoneal dialysis patients followed for about five years, having prealbumin above 40 mg/dL was actually associated with better survival. In this setting, the ratio of albumin to prealbumin provided better prognostic information than either marker alone.
In a study of 108 hospitalized adults compared against a detailed nutritional reference assessment, prealbumin correctly identified protein-energy malnutrition with about 83% sensitivity and 77% specificity. That means it catches roughly four out of five malnourished people and correctly clears about three out of four who are well nourished.
There is an important caveat. A systematic review of otherwise healthy people who were severely calorie-restricted, including hunger strikers and fasting study participants, found that prealbumin and albumin can remain normal until extreme starvation. In the absence of illness or inflammation, these proteins are poor standalone markers of undernutrition. The reason prealbumin works well in hospitals is precisely because sick people almost always have some degree of inflammation, which amplifies the nutritional signal.
The following tiers are drawn from a meta-analysis of malnutrition biomarkers in older adults and are widely used in clinical practice. Your lab may report slightly different reference intervals, so always compare your results within the same lab over time.
| Tier | Range (mg/dL) | What It Suggests |
|---|---|---|
| Normal | 20 to 40 | Adequate protein-energy balance in the absence of significant inflammation |
| Mild depletion | 10 to 20 | Possible protein-energy shortfall or moderate inflammatory suppression |
| Severe depletion | Below 10 | High malnutrition risk or significant systemic illness |
These thresholds work best when inflammation is accounted for. If your hs-CRP (high-sensitivity C-reactive protein, a standard inflammation marker) is elevated above roughly 10 to 15 mg/L, a low prealbumin may reflect inflammation rather than poor nutrition. Ordering both together gives you a much clearer picture.
No well-established age-specific, sex-specific, or ethnicity-specific reference intervals have been published for prealbumin. The meta-analysis notes that many older adults classified as high malnutrition risk by validated screening tools still had prealbumin above 20 mg/dL, suggesting these traditional cutpoints likely underdiagnose nutritional problems in aging populations.
Because prealbumin is a negative acute-phase reactant (meaning it falls during inflammation), anything that triggers inflammation will push it down regardless of how well you are eating. Keep these common confounders in mind:
A single prealbumin reading is a snapshot. Its real power comes from tracking changes over time. In a study of 3,136 ICU patients, admission prealbumin alone predicted mortality, but the change in prealbumin over the first week of treatment was an even stronger predictor, and it remained significant after adjusting for illness severity, inflammation, and calorie delivery. People whose prealbumin rose during the first week had markedly lower ICU death rates.
Because prealbumin turns over so quickly, you can see meaningful changes in just five to seven days when you alter your protein intake or resolve an inflammatory trigger. That speed makes it an excellent feedback tool. If you are making a dietary change, recovering from illness, or starting a new supplement protocol, retesting in one to two weeks can show whether the intervention is working.
For general preventive monitoring, get a baseline reading when you are feeling well and free of acute illness. If your result is in the normal range, retest annually or whenever your health circumstances change significantly (major illness, surgery, new chronic condition, or unintentional weight loss). If your result is below 20 mg/dL, retest within two to four weeks alongside hs-CRP to distinguish inflammation from true nutritional depletion.
If your prealbumin is in the normal range (20 to 40 mg/dL) and your hs-CRP is low, your protein-energy balance is likely adequate. File the result as your baseline and retest at your next annual check.
If your prealbumin is between 10 and 20 mg/dL, the next step is context. Check hs-CRP or standard CRP alongside it. If CRP is high, your low prealbumin may primarily reflect inflammation, and identifying the inflammatory source becomes the priority. If CRP is normal, the low reading more likely points to inadequate protein or calorie intake, and a review of your diet with attention to protein quality and quantity is warranted. A follow-up test in two to four weeks can confirm whether the trend is improving.
If your prealbumin is below 10 mg/dL, this is a strong signal that your body is under significant stress, whether from malnutrition, chronic inflammation, liver dysfunction, or a combination. Involve a physician to evaluate liver and kidney function, rule out hidden infection, and assess your nutritional status thoroughly. If you are of African descent and have any signs of heart failure, ask about screening for transthyretin amyloid cardiomyopathy, particularly the V142I variant.
Evidence-backed interventions that affect your Prealbumin level
Prealbumin is best interpreted alongside these tests.